Ivy Ray, NP
Nurse Practitioner · Anderson, SCNPI 1922623677
Payments from drug & device makers
Across 172 payments — averaging $20.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$480
- Mallinckrodt Hospital Products Inc.$375
- Amgen$303
- Vifor Pharma, Inc.$297
- Fresenius USA Marketing, Inc.$212
- Bayer$211
- plus $2K from 19 others
What the payments were for
- Food & beverage$3,28795%
- Education$1645%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 28 | $480 |
| Mallinckrodt Hospital Products Inc. | 16 | $375 |
| Amgen | 14 | $303 |
| Vifor Pharma, Inc. | 17 | $297 |
| Fresenius USA Marketing, Inc. | 12 | $212 |
| Bayer | 11 | $211 |
| Calliditas Therapeutics US Inc. | 9 | $205 |
| Novartis | 6 | $168 |
| Otsuka America Pharmaceutical, Inc. | 9 | $147 |
| Boehringer Ingelheim | 7 | $135 |
| Aurinia Pharma U.S., Inc. | 6 | $133 |
| Akebia Therapeutics Inc | 5 | $124 |
| Travere Therapeutics, Inc. | 6 | $118 |
| GSK | 5 | $111 |
| OPKO Pharmaceuticals, LLC | 4 | $74 |
| Daiichi Sankyo Inc. | 3 | $62 |
| Lilly USA, LLC | 4 | $62 |
| Ascendis Pharma Endocrinology Inc | 2 | $55 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 | $46 |
| Apellis Pharmaceuticals, Inc. | 1 | $35 |
| W. L. Gore & Associates, Inc. | 1 | $22 |
| Kyowa Kirin, Inc. | 1 | $22 |
| Scpharmaceuticals Inc. | 1 | $20 |
| Novo Nordisk | 1 | $19 |
| Ultragenyx Pharmaceutical Inc. | 1 | $16 |
How this compares
$3,451 in reported general payments places this provider in the 90th percentile of 1,346 nurse practitioner providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VelphoroSucroferric Oxyhydroxide | 16 | $48,021 |
| FarxigaDapagliflozin Propanediol | 50 | $40,213 |
| AuryxiaFerric Citrate | 19 | $35,231 |
| VeltassaPatiromer Calcium Sorbitex | 40 | $25,310 |
| JardianceEmpagliflozin | 11 | $10,259 |
| LokelmaSodium Zirconium Cyclosilicate | 19 | $5,630 |
| Nicardipine Hcl | 13 | $5,533 |
| Sevelamer Carbonate | 66 | $5,249 |
| Calcium Acetate | 37 | $3,773 |
| Nifedipine ErNifedipine | 34 | $745 |
| Hydralazine Hcl | 28 | $661 |
| Losartan Potassium | 60 | $624 |
| Chlorthalidone | 31 | $455 |
| Calcitriol | 43 | $436 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 13 | $221 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Fresenius USA Marketing, Inc.Velphoro | $212 | $48,02116 claims |
| AstraZenecaFarxiga, Lokelma | $480 | $45,84369 claims |
| Akebia Therapeutics IncAuryxia | $124 | $35,23119 claims |
| Boehringer IngelheimJardiance | $135 | $10,25911 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,346 nurse practitioner providers in South Carolina.
Other nurse practitioner in Anderson
- Owen MurryAnderson$8K
- Sherri CheekAnderson$8K
- Ashley BlackAnderson$8K
- Gayla PattersonAnderson$7K
- Jenna DavisColumbia$202K
- David WiltGreenville$90K
- Whitney ReedCharleston$54K
- Mary JohnsonCharleston$34K
- Amanda HareCharleston$30K
- Kellie McLainCharleston$28K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.